Breakthrough Technologies Could Revolutionize Omega Delivery Systems







These actions have paved the way for a number of companies looking to capitalize on non-psychogenic cannabinoid compounds. While the FDA has butted heads with both the labeling and sale of non-psychogenic cannabinoids, like cannabidiol (“CBD”), the U.S. government itself holds a patent covering the use of cannabinoids as antioxidants and neuro-protectants.

A growing body of research suggests that cannabinoids like CBD could prove both safe and efficacious in treating conditions ranging from Alzheimer’s disease to pain management to certain types of cancers. In this article, we will take a look at why CBD represents a compelling niche within the cannabis industry and how Naturally Splendid Enterprises‘ ( NSP.V ) ( NSPDF ) innovative extraction technology is changing the game.

To read more, visit

Posted in: News

Comments are closed.